Trial Outcomes & Findings for Adjunct Inversion for Lower Pole Stone (NCT NCT01852669)

NCT ID: NCT01852669

Last Updated: 2015-04-20

Results Overview

To compare the effectiveness of simultaneous adjunct controlled inversion therapy during extracorporeal shockwave lithotripsy (ESWL) to that of ESWL alone in the treatment of lower pole caliceal stone as measured by stone-free rate(SFR)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

140 participants

Primary outcome timeframe

3 months

Results posted on

2015-04-20

Participant Flow

Participant milestones

Participant milestones
Measure
Inversion, Hydration, ESWL
ESWL with hydration and inversion Inversion: Patients inverted 30 degree head down in Trendelenburg position Shock Wave Lithotripsy: Shock wave lithotripsy Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV
ESWL, Hydration
ESWL with hydration Shock Wave Lithotripsy: Shock wave lithotripsy Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV
Overall Study
STARTED
71
69
Overall Study
COMPLETED
71
68
Overall Study
NOT COMPLETED
0
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Adjunct Inversion for Lower Pole Stone

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Inversion, Hydration, ESWL
n=71 Participants
ESWL with hydration and inversion Inversion: Patients inverted 30 degree head down in Trendelenburg position Shock Wave Lithotripsy: Shock wave lithotripsy Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV
ESWL, Hydration
n=68 Participants
ESWL with hydration Shock Wave Lithotripsy: Shock wave lithotripsy Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV
Total
n=139 Participants
Total of all reporting groups
Age, Continuous
48.3 years
STANDARD_DEVIATION 11.1 • n=5 Participants
50.9 years
STANDARD_DEVIATION 12.9 • n=7 Participants
49.63 years
STANDARD_DEVIATION 12.0 • n=5 Participants
Sex: Female, Male
Female
20 Participants
n=5 Participants
21 Participants
n=7 Participants
41 Participants
n=5 Participants
Sex: Female, Male
Male
51 Participants
n=5 Participants
47 Participants
n=7 Participants
98 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 3 months

To compare the effectiveness of simultaneous adjunct controlled inversion therapy during extracorporeal shockwave lithotripsy (ESWL) to that of ESWL alone in the treatment of lower pole caliceal stone as measured by stone-free rate(SFR)

Outcome measures

Outcome measures
Measure
Inversion, Hydration, ESWL
n=71 Participants
ESWL with hydration and inversion Inversion: Patients inverted 30 degree head down in Trendelenburg position Shock Wave Lithotripsy: Shock wave lithotripsy Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV
ESWL, Hydration
n=68 Participants
ESWL with hydration Shock Wave Lithotripsy: Shock wave lithotripsy Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV
Number of Participants Who Are Stone Free at 3 Months
54 participants
49 participants

Adverse Events

Inversion, Hydration, ESWL

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

ESWL, Hydration

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Inversion, Hydration, ESWL
n=71 participants at risk
ESWL with hydration and inversion Inversion: Patients inverted 30 degree head down in Trendelenburg position Shock Wave Lithotripsy: Shock wave lithotripsy Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV
ESWL, Hydration
n=68 participants at risk
ESWL with hydration Shock Wave Lithotripsy: Shock wave lithotripsy Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV
Blood and lymphatic system disorders
Haematoma
1.4%
1/71 • Number of events 1
2.9%
2/68 • Number of events 2

Additional Information

Dr Shaun Lee

Monash University

Phone: 55145890

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place